Precision Biosciences Stock Buy Hold or Sell Recommendation
| DTIL Stock | USD 10.72 0.79 6.86% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Precision BioSciences is 'Strong Sell'. Macroaxis provides Precision BioSciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DTIL positions. The advice algorithm takes into account all of Precision BioSciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Precision BioSciences' buy or sell advice are summarized below:
Real Value 7.04 | Target Price 3.07 | Hype Value 11.55 | Market Value 10.72 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Precision BioSciences given historical horizon and risk tolerance towards Precision BioSciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Precision BioSciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Precision |
Execute Precision BioSciences Buy or Sell Advice
The Precision recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Precision BioSciences. Macroaxis does not own or have any residual interests in Precision BioSciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Precision BioSciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Precision BioSciences Trading Alerts and Improvement Suggestions
| Precision BioSciences had very high historical volatility over the last 90 days | |
| Precision BioSciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 48.73 M. Net Loss for the year was (42.53 M) with profit before overhead, payroll, taxes, and interest of 25.1 M. | |
| Precision BioSciences currently holds about 184.14 M in cash with (84.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. | |
| Precision BioSciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration |
Precision BioSciences Returns Distribution Density
The distribution of Precision BioSciences' historical returns is an attempt to chart the uncertainty of Precision BioSciences' future price movements. The chart of the probability distribution of Precision BioSciences daily returns describes the distribution of returns around its average expected value. We use Precision BioSciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Precision BioSciences returns is essential to provide solid investment advice for Precision BioSciences.
| Mean Return | 0.06 | Value At Risk | -7.51 | Potential Upside | 9.28 | Standard Deviation | 6.67 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Precision BioSciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Precision Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Precision BioSciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Precision BioSciences backward and forwards among themselves. Precision BioSciences' institutional investor refers to the entity that pools money to purchase Precision BioSciences' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Moloney Securities Asset Management | 2023-12-31 | 890.2 K | Tejara Capital Ltd | 2023-12-31 | 743 K | Bank Of America Corp | 2023-09-30 | 673.4 K | Chi Advisors Llc | 2023-09-30 | 606.6 K | Goldman Sachs Group Inc | 2023-09-30 | 474.1 K | Jacob Asset Mgmt Of Ny Llc | 2023-09-30 | 390.4 K | Curi Wealth Management, Llc | 2023-12-31 | 340 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 334.1 K | Millennium Management Llc | 2023-09-30 | 293.7 K | Capital World Investors | 2023-12-31 | 5.1 M | Vanguard Group Inc | 2023-09-30 | 4.7 M |
Precision BioSciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 77.7M | (91.1M) | 53.9M | 45.9M | (72.9M) | (69.3M) | |
| Depreciation | 5.3M | 9.8M | 10.2M | 9.0M | 8.3M | 6.5M | |
| Capital Expenditures | 24.7M | 5.0M | 5.8M | 3.3M | 2.3M | 2.2M | |
| Net Income | (92.9M) | (109.0M) | (30.6M) | (111.6M) | (42.5M) | (44.7M) | |
| End Period Cash Flow | 180.9M | 89.8M | 143.7M | 189.6M | 116.7M | 134.8M | |
| Change To Netincome | 18.9M | 13.8M | (10.1M) | 32.8M | 37.8M | 39.6M | |
| Investments | (24.7M) | (5.0M) | (5.8M) | (3.3M) | 5.2M | 5.4M | |
| Free Cash Flow | (95.7M) | (92.4M) | (16.7M) | (49.1M) | (86.4M) | (90.7M) | |
| Other Non Cash Items | 9.9M | 35K | (20.4M) | 13.6M | (21.1M) | (20.0M) |
Precision BioSciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Precision BioSciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Precision BioSciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Precision stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.03 | |
β | Beta against NYSE Composite | 0.43 | |
σ | Overall volatility | 6.81 | |
Ir | Information ratio | 0.0007 |
Precision BioSciences Volatility Alert
Precision BioSciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Precision BioSciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Precision BioSciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Precision BioSciences Fundamentals Vs Peers
Comparing Precision BioSciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Precision BioSciences' direct or indirect competition across all of the common fundamentals between Precision BioSciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Precision BioSciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Precision BioSciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Precision BioSciences to competition |
| Fundamentals | Precision BioSciences | Peer Average |
| Return On Equity | -1.07 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Profit Margin | (1.26) % | (1.27) % |
| Operating Margin | (2.12) % | (5.51) % |
| Current Valuation | 3.6 M | 16.62 B |
| Shares Outstanding | 6.92 M | 571.82 M |
| Shares Owned By Insiders | 8.47 % | 10.09 % |
| Shares Owned By Institutions | 39.76 % | 39.21 % |
| Number Of Shares Shorted | 288.87 K | 4.71 M |
| Price To Earning | (6.10) X | 28.72 X |
| Price To Book | 5.18 X | 9.51 X |
| Price To Sales | 2.00 X | 11.42 X |
| Revenue | 48.73 M | 9.43 B |
| Gross Profit | 25.1 M | 27.38 B |
| EBITDA | (35.48 M) | 3.9 B |
| Net Income | (42.53 M) | 570.98 M |
| Cash And Equivalents | 184.14 M | 2.7 B |
| Cash Per Share | 1.66 X | 5.01 X |
| Total Debt | 31.27 M | 5.32 B |
| Debt To Equity | 0.27 % | 48.70 % |
| Current Ratio | 4.59 X | 2.16 X |
| Book Value Per Share | 4.53 X | 1.93 K |
| Cash Flow From Operations | (84.11 M) | 971.22 M |
| Short Ratio | 1.31 X | 4.00 X |
| Earnings Per Share | (332.12) X | 3.12 X |
| Target Price | 35.8 | |
| Number Of Employees | 109 | 18.84 K |
| Beta | 1.57 | -0.15 |
| Market Capitalization | 89.01 M | 19.03 B |
| Total Asset | 159.78 M | 29.47 B |
| Retained Earnings | (489.63 M) | 9.33 B |
| Working Capital | 86.37 M | 1.48 B |
| Current Asset | 174.05 M | 9.34 B |
Note: Acquisition by John Kelly of 20000 shares of Precision BioSciences at 0.86 subject to Rule 16b-3 [view details]
Precision BioSciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Precision . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Precision BioSciences Buy or Sell Advice
When is the right time to buy or sell Precision BioSciences? Buying financial instruments such as Precision Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 11.8M | 10.2M | 11.4M | 7.1M | Total Assets | 211.5M | 238.2M | 159.8M | 179.4M |
Use Investing Ideas to Build Portfolios
In addition to having Precision BioSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Thematic Idea Now
Communication
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Precision BioSciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (332.12) | Revenue Per Share 12.685 | Quarterly Revenue Growth (0.34) | Return On Assets (0.14) | Return On Equity (1.07) |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.